Expression patterns of integrin receptors and extracellular matrix proteins in chronic rejection of human liver allografts

Transplant Immunology

Volumn 7, Issue 4, 1999, Pages 229-237

  Demirci, Gülçin ^a   Hoshino, Ken ^b   Nashan, Björn ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; INTEGRIN RECEPTOR; SCLEROPROTEIN; VERY LATE ACTIVATION ANTIGEN 1; VERY LATE ACTIVATION ANTIGEN 5; VERY LATE ACTIVATION ANTIGEN 6;

ALLOGRAFT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; HEPATITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LIVER SINUSOID; LIVER TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033396835     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(99)80007-0     Document Type: Article

References (32)

1. Springer TA. Adhesion receptors of the immune system. Nature. 346:1990;425-434.
2. Butcher EC. Cellular and molecular mechanisms that direct leucocyte traffic. Am J Pathol. 136:1990;3-11.
3. Ruszczak Z, Schwartz RA. Vascular endothelium in the regulation of immune response. Res Commun Mol Pathol Phamacol. 94:1996;3-21.
4. Jaeschke H. Cellular adhesion molecules: regulation and functional significance in the pathogenesis of liver disease. Am J Physiol. 273:1997;G602-G611.
5. Ruoslahti E. Integrins. J Clin Invest. 87:1991;1-5.
6. Lasky LA. Selectins: Interpreters of cell-specific carbohydrate information during inflammation. Science. 258:1992;964-969.
7. Williams AF, Barclay AN. The immunoglobulin superfamily - domains for cell surface recognition. Annu Rev Immunol. 6:1988;381-405.
8. Van den Oord JJ. Adhesion molecules. Hepatogastroenterology. 43:1996;1100-1102.
9. Ruoslahti JA, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science. 238:1987;491-497.
10. McDonald JA. Receptors for extracellular matrix components. Am J Physiol. 257:1989;L331-L337.
11. Volpes R, Van den Oord JJ, Desmet VJ. Distribution of the VLA family of integrins in normal and pathological human liver tissue. Gastroenterology. 101:1991;200-206.
12. Alon R, Kassner PD, Carr MW, Finger EB, Hemler ME, Springer TA. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol. 128:1995;1243-1253.
13. Elices MJ, Osborn L, Takada Y, et al. VCAM-1 on activated endothelium interacts with the leucocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell. 60:1990;577-584.
14. Stamatoglou SC, Hughes RC. Cell adhesion molecules in liver function and pattern formation. FASEB J. 8:1994;420-427.
15. Scoazec JY. Adhesion molecules in normal human liver. Hepatogastroenterology. 43:1996;1103-1105.
16. Scoazec JY. Expression of cell-matrix adhesion molecules in the liver and their modulation during fibrosis. J Hepatol. 22:1995;20-27.
17. Coulevard A, Scoazec JY, Feldman G. Expression of cell-cell and cell-matrix adhesion molecules by sinusoidal endothelial cells in the normal and cirrhotic human liver. Am J Pathol. 143:1993;738-752.
18. Garcia-Monzon C, Garcia-Buey L, Majano PL, Moreno-Otero R. Integrins: structure, bilogical functions and relevance in viral chronic hepatitis. Eur J Clin Invest. 25:1995;71-78.
19. Garcia-Monzon C, Moreno-Otero R, Garcia-Buey L, Garcia-Sanchez A, Campanero MR, Sanchez-Madrid F. Intrahepatic upregulated expression of extracellular matrix protein receptors in chronic active hepatitis type B. Gastroenterology. 102:1992;255-262.
20. Adams DH, Hubscher SG, Shaw J, et al. Increased expression of intercellular adhesion molecule-1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology. 14:1991;426-431.
21. Fisher N, Afford S, Adams DH. Adhesion molecules and alcoholic liver disease. Hepatogastroenterology. 43:1996;1113-1116.
22. Steinhoff G, Behrend M, Schrader B, Pichlmayr R. Intercellular immune adhesion molecules in human liver transplants: Overview on expression patterns of leucocyte receptor and ligand molecules. Hepatology. 18:1993;440-453.
23. Heeman UW, Tullius SG, Azuma H, Kupiec-Weglinsky J, Tilney NL. Adhesion molecules and transplantation. Ann Surg. 219:1994;4-12.
24. Rodriguez-Iturbe B. Cellular adhesion molecules in transplantation. Transplant Proc. 28:1996;3285-3289.
25. Freese DK, Snover DC, Sharp HL, Gross CR, Savick SK, Payne WD. Chronic rejection after liver transplantation: a study of clinical, histopathological and immunological features. Hepatology. 13:1991;882-891.
26. Kemnitz J, Gubernatis G, Bunzendahl H, Ringe B, Pichlmayr R, Georgii A. Criteria for the histopathological classification of liver allograft rejection and their clinical relevance. Transplant Proc. 21:1989;2208-2210.
27. Demirci G, Nashan B, Pichlmayr R. Fibrosis in chronic rejection of human liver allografts. Expression patterns of transforming growth factor - TGF-β1 and TGF-β3. Transplantation. 62:1996;1776-1783.
28. Darribere T, Guida K, Larjava H, et al. In vivo analyses of integrin β1 subunit function in fibronectin matrix assembly. J Cell Biol. 110:1990;1813-1823.
29. Van Hoek B, Wiesner RH, Krom RAF, Ludwig J, Moore SB. Severe ductopenic rejection after liver transplantation: incidence, time of onset, risk factors, treatment, and outcome. Semin Liver Dis. 12:1992;41-50.
30. Ludwig J, Gross JB, Perkins JD, Moore SB. Persistent centrilobular necroses in hepatic allografts. Hum Pathol. 21:1990;656-661.
31. Garcia-Monzon C, Sanchez-Madrid F, Garcia-Buey L, Garcia-Arroyo A, Garcia-Sanchez A., Moreno-Otero R. Vascular adhesion molecules expression in viral chronic hepatitis. Evidence of neo-angiogenesis in portal tracts. Gastroenterology. 108:1995;231-241.
32. Hahn E, Wick G, Pencev D, Timpl R. Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin and fibronectin. Gut. 21:1980;63-71.